Studi penggunaan obat pada penderita diabetes mellitus tipe 2 dengan komplikasi nefropati

Felicita Hindarto, 050112440 (2005) Studi penggunaan obat pada penderita diabetes mellitus tipe 2 dengan komplikasi nefropati. Skripsi thesis, UNIVERSITAS AIRLANGGA.


Download (2MB) | Preview
[img] Text (FULLTEXT)
Restricted to Registered users only

Download (805kB)
Official URL:


Diabetic nephropathy is the most common cause of renal failure. The mortality rate from all causes in diabetic patients with nephropathy is 20-40 times higher than that of patients without nephropathy. In this study, the drug utilization profile on type 2 diabetic patient with nephropathy was analyzed descriptively used patient’s medical records by retrospective method. The results showed that patients with type 2 diabetic nephropathy use either ACEIs,CCBs, ARBs, ACEI and diuretic, ACEI and CCB as their antihypertensive therapy; insulin to control blood glucose intensively; the third generation cephalosporins antibiotics for urinary tract infection therapy; sodium bicarbonat, calsium carbonat or calsium gluconas for therapy of body electrolite imbalance; aspirin and dipiridamol as antiplatelet/haemoreology agents; H2 receptor antagonist as stress ulcer therapy; Packed Red Cell/PRC tranfusion as anemia therapy; allopurinol as hyperuricemia therapy; etc. Drug therapy of type 2 diabetic patient with nephropathy is quite complicated because it depends on the clinical presentation of patient. Diabetic nephropathy needs some potential therapeutic strategies primarily in the treatment proteinuria with the ACEI and/or ARBs, intensive blood pressure control, and intensive blood glucose control to prevent the proteinuria progression and the renal function’s decline. Further study is needed to learn more (dose, adverse drugs reaction, etc) about drug utilization of type 2 diabetic patient with nephropathy

Item Type: Thesis (Skripsi)
Additional Information: Koleksi Ruang Baca, FF 1955/FF/05 Hin s
Uncontrolled Keywords: type 2 diabetic nephropathy, ACEI, drug utilization study
Subjects: R Medicine > RC Internal medicine > RC31-1245 Internal medicine
R Medicine > RM Therapeutics. Pharmacology > RM300-666 Drugs and their actions
Divisions: 05. Fakultas Farmasi
Felicita Hindarto, 050112440UNSPECIFIED
ContributionNameNIDN / NIDK
Thesis advisorYulistiani, Dra., MSi., Apt.UNSPECIFIED
Thesis advisorSri Murtiwi, dr., SpPD-KEMDUNSPECIFIED
Thesis advisorEndang Martiniani, Dra., M.Pharm., Apt.UNSPECIFIED
Depositing User: petugas
Date Deposited: 12 Dec 2016 19:11
Last Modified: 12 Dec 2016 19:11
Sosial Share:

Actions (login required)

View Item View Item